Cargando…

Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study

Objective To examine the risk of community acquired pneumonia before and after prescription of proton pump inhibitor (PPI) and assess whether unmeasured confounding explains this association. Design Cohort study and self controlled case series. Setting Clinical Practice Research Datalink (1990 to 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Othman, Fatmah, Crooks, Colin J, Card, Timothy R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110150/ https://www.ncbi.nlm.nih.gov/pubmed/28715344 http://dx.doi.org/10.1136/bmj.i5813

Ejemplares similares

Proton‐Pump Inhibitors and Long‐Term Risk of Community‐Acquired Pneumonia in Older Adults
por: Zirk‐Sadowski, Jan, et al.
Publicado: (2018)

Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis
por: Filion, Kristian B, et al.
Publicado: (2014)

Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis
por: Lambert, Allison A., et al.
Publicado: (2015)

Proton Pump Inhibitors: Exploring Cardiovascular Complications and Prescription Protocol
por: Sarnaik, Mubashira K, et al.
Publicado: (2021)

Appropriateness of Proton Pump Inhibitor Prescription Evaluated by Using Serological Markers
por: Russo, Michele, et al.
Publicado: (2023)

Co-prescription of Dual-Antiplatelet Therapy and Proton Pump Inhibitors: Current Guidelines
por: Saven, Hannah, et al.
Publicado: (2022)

Prescriptive Appropriateness: Inhospital Adherence to Proton Pump Inhibitors Deprescription Flow Chart
por: Baiardi, Giammarco, et al.
Publicado: (2023)

The comparison between proton pump inhibitors and sucralfate in incidence of ventilator associated pneumonia in critically ill patients
por: Khorvash, Farzin, et al.
Publicado: (2014)

Effect of proton pump inhibitors on mortality of cirrhotic patients with pneumonia
por: Hung, Tsung-Hsing, et al.
Publicado: (2019)

Effects of proton pump inhibitor use on the esophageal microbial community
por: Tasnim, Sadia, et al.
Publicado: (2020)

Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors
por: Hojo, Mariko, et al.
Publicado: (2018)

Prescription of antibiotics in community-acquired pneumonia in children: are we following the recommendations?
por: da Fonseca Lima, Eduardo Jorge, et al.
Publicado: (2016)

Proton pump inhibitors and the risk of hospital-acquired acute kidney injury in children
por: Li, Yanqin, et al.
Publicado: (2020)

Association of Proton Pump Inhibitor Use With Risk of Acquiring Drug-Resistant Enterobacterales
por: Willems, Roel P. J., et al.
Publicado: (2023)

Population-based incidence and mortality of community-acquired pneumonia in Germany
por: Theilacker, Christian, et al.
Publicado: (2021)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the Canadian pharmacist
por: Armstrong, David, et al.
Publicado: (2016)

Proton pump inhibitors and the incidence of Clostridium difficile on the intensive care unit
por: Whitehead, I, et al.
Publicado: (2007)

Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia
por: Donà, Daniele, et al.
Publicado: (2018)

Regular proton pump inhibitor use and incident dementia: population-based cohort study
por: Zhang, Peidong, et al.
Publicado: (2022)

Incidence of Antibiotic Treatment Failure in Patients with Nursing Home-Acquired Pneumonia and Community Acquired Pneumonia
por: Lopes, Mariana, et al.
Publicado: (2021)

Potentially inappropriate proton-pump inhibitor prescription in the general population: a claims-based retrospective time trend analysis
por: Muheim, Leander, et al.
Publicado: (2021)

Low adherence to national guidelines for proton-pump inhibitor prescription in patients receiving combination aspirin and anticoagulation
por: Sharma, Rajani, et al.
Publicado: (2017)

Lifestyle‐ and comorbidity‐related factors for the prescription of proton pump inhibitors after Helicobacter pylori eradication in Japan
por: Shimada, Furitsu, et al.
Publicado: (2021)

Inappropriate proton pump inhibitor lansoprazole prescription in older adults hospitalized in long-term care unit
por: Ladjouzi, Nadia, et al.
Publicado: (2022)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Proton Pump Inhibitor Therapy before and after Endoscopic Submucosal Dissection: A Review
por: Sugimoto, Mitsushige, et al.
Publicado: (2012)

Proton Pump Inhibitor Use before Percutaneous Endoscopic Gastrostomy Is Associated with Adverse Outcomes
por: Im, Jong Pil, et al.
Publicado: (2014)

Incidence and Prevalence of Celiac Disease and Dermatitis Herpetiformis in the UK Over Two Decades: Population-Based Study
por: West, Joe, et al.
Publicado: (2014)

Incidence, Etiology, and Outcomes of Community-Acquired Pneumonia: A Population-Based Study
por: Bjarnason, Agnar, et al.
Publicado: (2018)

Proton Pump Inhibitors and the Risk of Adverse Cardiac Events
por: Juurlink, David N., et al.
Publicado: (2013)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients
por: Barletta, Jeffrey F, et al.
Publicado: (2014)

Prescription behavior for gastroprotective drugs in new users as a result of communications regarding clopidogrel – proton pump inhibitor interaction
por: Kruik‐Kollöffel, Willemien J., et al.
Publicado: (2016)

Excess Long-Term Mortality following Non-Variceal Upper Gastrointestinal Bleeding: A Population-Based Cohort Study
por: Crooks, Colin John, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_o2p179n3is95ugn0rc16o3jl7t